InvestorsHub Logo
Followers 58
Posts 10035
Boards Moderated 1
Alias Born 09/21/2016

Re: nobrainerstocks post# 110321

Wednesday, 07/05/2017 5:52:12 PM

Wednesday, July 05, 2017 5:52:12 PM

Post# of 458325
Nobrainer, thx for the link. Just when you think you are having a very bad day you realize what some of these patients and their families must go through...it is just sooo good to see a positive 3rd party write up saying nice things about A273...this is ALL gonna be worth it when these pts and our SP recovers.

So, the latest news detailed some preclinical results from an investigation into the potential application of ANAVEX 2-73 in a condition called Angelman syndrome. This one’s an autism spectrum disorder that occurs in one in 15,000 live births and it’s characterized by severe cognitive and physical impairments, including ataxia, intellectual disability, speech impairment, sleep disorders, and seizures.
It’s a big unmet need and the latest data suggests that ANAVEX 2-73 could be effective in treating it. The results indicated that ANAVEX 2-73 administration significantly reduced audiogenic-induced seizures, which are a debilitating symptom that affect more than 80% of sufferers."

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News